Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hioe

Showing results (111-120 of 157) with videos related to

Pageof 16
Sort By:
Leukemia Research|September 15, 2009
Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cellsScott C Kachlany, Amy B Schwartz, Nataliya V Balashova, et al.
AIDS Research and Human Retroviruses|June 30, 2000
Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120C E Hioe, G J Jones, A D Rees, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Identification of an N-linked glycosylation in the C4 region of HIV-1 envelope gp120 that is critical for recognition of neighboring CD4 T cell epitopesHualin Li, Peter C Chien, Michael Tuen, et al.
European Journal of Immunology|August 18, 2005
Characterization of antibodies that inhibit HIV gp120 antigen processing and presentationMichael Tuen, Maria Luisa Visciano, Peter C Chien, et al.
Journal of Virology|September 16, 2016
Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody ResponseSusan Zolla-Pazner, Rebecca Powell, Sara Yahyaei, et al.
Plos One|August 19, 2011
HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA)Catarina E Hioe, Michael Tuen, Gaia Vasiliver-Shamis, et al.
Food Research International (Ottawa, Ont.)|December 3, 2017
Probiotic-loaded microcapsule system for human in situ folate production: Encapsulation and system validationPhilippe E Ramos, Luís Abrunhosa, Ana Pinheiro, et al.
AIDS Research and Human Retroviruses|March 10, 1998
A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 cladesM K Gorny, J R Mascola, Z R Israel, et al.
The Journal of Infectious Diseases|February 21, 2004
HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentationPeter C Chien, Daniel Chen, Pei-De Chen, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|January 30, 2016
Comparison of fluorescence in-situ hybridisation with dual-colour in-situ hybridisation for assessment of HER2 gene amplification of breast cancer in Hong KongScott M C Tang, Inda S Soong, M Y Luk, et al.
Pageof 16

Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
Leukemia Research|September 15, 2009
Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cellsScott C Kachlany, Amy B Schwartz, Nataliya V Balashova, et al.
AIDS Research and Human Retroviruses|June 30, 2000
Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120C E Hioe, G J Jones, A D Rees, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Identification of an N-linked glycosylation in the C4 region of HIV-1 envelope gp120 that is critical for recognition of neighboring CD4 T cell epitopesHualin Li, Peter C Chien, Michael Tuen, et al.
European Journal of Immunology|August 18, 2005
Characterization of antibodies that inhibit HIV gp120 antigen processing and presentationMichael Tuen, Maria Luisa Visciano, Peter C Chien, et al.
Journal of Virology|September 16, 2016
Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody ResponseSusan Zolla-Pazner, Rebecca Powell, Sara Yahyaei, et al.
Plos One|August 19, 2011
HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA)Catarina E Hioe, Michael Tuen, Gaia Vasiliver-Shamis, et al.
Food Research International (Ottawa, Ont.)|December 3, 2017
Probiotic-loaded microcapsule system for human in situ folate production: Encapsulation and system validationPhilippe E Ramos, Luís Abrunhosa, Ana Pinheiro, et al.
AIDS Research and Human Retroviruses|March 10, 1998
A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 cladesM K Gorny, J R Mascola, Z R Israel, et al.
The Journal of Infectious Diseases|February 21, 2004
HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentationPeter C Chien, Daniel Chen, Pei-De Chen, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|January 30, 2016
Comparison of fluorescence in-situ hybridisation with dual-colour in-situ hybridisation for assessment of HER2 gene amplification of breast cancer in Hong KongScott M C Tang, Inda S Soong, M Y Luk, et al.
Pageof 16